ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2024

Drug Safety Evaluation of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Comorbid Patients by Review of Systemic Extraglycemic Effects.

Mohammad Belal Omari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.